Microencapsulation of hepatitis B core antigen for vaccine preparation

Pharmaceutical Research

Volumn 15, Issue 11, 1998, Pages 1708-1713

  Uchida, Takahiro ^a   Shiosaki, Kouichi ^b   Nakada, Yoichi ^c   Fukada, Katsuhiko ^b   Eda, Yasuyuki ^b   Tokiyoshi, Sachio ^b   Nagareya, Noriko ^a   Matsuyama, Kenji ^a  

^a MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^b Chemo Sero Therapeutic Research Institute   (Japan)

^c TORAY INDUSTRIES INC   (Japan)

Author keywords

ELISA; Hepatitis B core antigen; Microspheres; Poly(lactide co glycolide); Vaccine

Indexed keywords

FREUND ADJUVANT; HEPATITIS B CORE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; MICROSPHERE; POLYGLACTIN; POLYVINYL ALCOHOL;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG ANTIGENICITY; DRUG STABILITY; FEMALE; HEPATITIS B VIRUS; MICROENCAPSULATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SUSTAINED DRUG RELEASE; VACCINE PRODUCTION; VIRUS CORE;

ANIMALS; DRUG COMPOUNDING; DRUG STABILITY; FEMALE; HEPATITIS B CORE ANTIGENS; HEPATITIS B VACCINES; MICE; MICE, INBRED BALB C; MICROSPHERES; MOLECULAR WEIGHT;

EID: 0031758514     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011904627929     Document Type: Article

References (17)

1. J. Freund. The effect of paraffin oil and mycobacteria on antibody formation and sensitization. Am. J. Clin. Pathol. 21:645-656 (1951).
2. G. W. Beebe, A. H. Simon, and S. Vivona. Long-term mortality follow up of army recruits who received adjuvant influenza virus vaccine. Am. J. Epidemiol. 95:337-344 (1972)
3. D. T. O'Hagan, K. Palin, S. S. Davis, P. Artursson, and I. Sjoholm. Microparticles as potentially orally active immunological adjuvants. Vaccine 7:421-424 (1989).
4. J. H. Eldridge, C. J. Hammond, J. A. Meulbroek, J. K. Staas, R. M. Gilley, and T. R. Tice. Controlled vaccine release in the gut-associated lymphoid tissues 1. Orally administered biodegradable microspheres target in the Peyer's patches. J. Contr. Rel. 11:205-214 (1990).
5. T. Uchida, S. Martin, T. P. Foster, R. C. Wardley, and R. C. Grimm. Dose and load studies for subcutaneous and oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin. Pharm. Res. 11:1009-1015 (1994).
6. T. Uchida and S. Goto. Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study. Biol. Pharm. Bull. 17:1272-1276 (1994).
7. T. Uchida, S. Goto, and T. P. Foster. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation. J. Pharm. Pharmacol. 46:1214-1221 (1995).
8. R. V. Nellore, P. G. Pande, D. Young, and H. R. Bhagat. Evaluation of biodegradable microspheres as vaccine adjuvant for hepatitis B surface antigen. J. Parent. Sci. & Tech. 46:176-180 (1992).
9. N. Nath, K. Hickman, S. Nowlan, D. Shah, J. Philips, and S. Babler. Stability of the recombinant hepatitis B core antigen. J. Clin. Microbio. 30:1617-1619 (1992).
10. A. Budkowska, A. Kalinowska, and A. Nowoslawski. Identification of two HBeAg subspecificities revealed by chemical treatment and enzymatic digestion of liver-derived HBcAg. J. Immunol. 123:1415-1416 (1979).
11. T. Uchida, A. Yagi, Y. Oda, and S. Goto. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by oil-in-oil (o/o) solvent evaporation method. J. Microencapsulation 13:509-518 (1996).
12. S. Benita, J. P. Benoit, F. Puisieux, and C. Thies. Characterization of drug loaded poly (dl-lactide) microspheres. J. Contr. Rel. 73:1721-1724 (1984).
13. P. Edman, E. Bjork, and L. Ryden. Microspheres as a nasal delivery system for peptide drugs. J. Contr. Rel. 21:165-172 (1993).
14. T. Heya, H. Okada, Y. Tanigawara, Y. Ogawa, and H. Toguchi. Effects of counteranion of TRH and loading amount on control of TRH release from copoly (dl-lactic/glycolic acid) microspheres prepared by an in-water drying method. Int. J. Pharm. 69:69-75 (1991).
15. Y.-L. Lai, R. C. Mehata, A. A. Thacker, S.-D. Yoo, P. J. McNamara, and P. P. DeLuca. Sustained bronchodilation with isoproterenol poly(glycolide-co-lactide) microspheres. Pharm. Res. 10:119-125 (1993).
16. Y. Ogawa, Y. M. Yamamoto, S. Takada, H. Okada, and T. Shimamoto. Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer. Chem. Pharm. Bull. 36:1095-1103 (1988).
17. P. G. Jani, W. Halbert, J. Langridge, and A. T. Florence. The uptake and translocation of latex nonospheres and microspheres after oral administration to rats. J. Pharm. Pharmacol. 41:809-812 (1989).